Catalyst Private Wealth
ABBV icon

Catalyst Private Wealth’s AbbVie ABBV Stock Holding History

Catalyst Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$241K Buy
921
+72
+8% +$18.5K 0.1% 87
2026
Q2 		$214K Buy
+849
New +$183K 0.1% 79
2020
Q4 		– Sell
-485
Closed -$42K – 58
2020
Q3 		$42K Buy
+485
New +$45.7K 0.04% 123

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Catalyst Private Wealth's ABBV Position: Q3 2026 in Review

Catalyst Private Wealth increased its AbbVie (ABBV) stake by 8.5% in Q3 2026, buying an estimated $18.5K and bringing the position to 921 shares worth $241K. The position accounts for 0.1% of the portfolio, ranked #87.

Catalyst Private Wealth first reported a position in ABBV in Q3 2020 and has held it in 3 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Catalyst Private Wealth held 921 shares of AbbVie worth $241K as of Q3 2026.
  • Catalyst Private Wealth bought 72 AbbVie shares in Q3 2026, an estimated $18.5K.
  • AbbVie made up 0.1% of Catalyst Private Wealth's portfolio in Q3 2026, its #87 holding.
  • Catalyst Private Wealth first reported a position in AbbVie in Q3 2020 and has held it in 3 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Catalyst Private Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.